• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溃疡性结肠炎的袋炎预防与治疗。

Prevention and Medical Treatment of Pouchitis In Ulcerative Colitis.

机构信息

Desk A-30, Department of Colorectal Surgery, Digestive Disease Institute Cleveland Clinic, 9500 Euclid Ave. Cleveland, OH 44195, USA.

出版信息

Curr Drug Targets. 2019;20(13):1399-1408. doi: 10.2174/1389450120666190723130137.

DOI:10.2174/1389450120666190723130137
PMID:31333137
Abstract

Approximately 50% of patients who have undergone IPAA surgery for Ulcerative Colitis (UC) develop at least 1 episode of pouchitis. Patients with pouchitis have a wide range of symptoms, endoscopic and histologic features, disease course, and prognosis. To date, there are no universally accepted diagnostic criteria in terms of endoscopy and histology; though, semi-objective assessments to diagnose pouchitis in patients with ileal pouch- anal anastomosis (IPAA) have been proposed using composite scores such as the Pouchitis Triad, Heidelberg Pouchitis Activity Score and Pouchitis Disease Activity Index (PDAI). In a systematic review that included four randomized trials evaluating five agents for the treatment of acute pouchitis, ciprofloxacin was more effective at inducing remission as compared with metronidazole. Rifaximin was not more effective than placebo, while budesonide enemas and metronidazole were similarly effective for inducing remission of acute pouchitis. Patients with pouchitis relapsing more than three times per year are advised maintenance therapy, and guidelines recommend ciprofloxacin or the probiotic VSL#3. In patients with antibiotic-refractory pouchitis, secondary factors associated with an antibiotic-refractory course should be sought and treated. In this review, we will discuss the prevention and management of pouchitis in Ulcerative Colitis patients.

摘要

约有 50%接受回肠储袋肛管吻合术(IPAA)治疗溃疡性结肠炎(UC)的患者至少发生 1 次 pouchitis。 pouchitis 患者的症状、内镜和组织学特征、病程和预后差异很大。迄今为止,内镜和组织学方面尚无普遍接受的诊断标准;然而,已经提出了使用复合评分(如 pouchitis 三联征、海德堡 pouchitis 活动评分和 pouchitis 疾病活动指数)来诊断 IPAA 患者 pouchitis 的半客观评估。在一项纳入四项随机试验的系统评价中,评估了五种药物治疗急性 pouchitis 的效果,环丙沙星在诱导缓解方面比甲硝唑更有效。利福昔明并不比安慰剂更有效,而布地奈德灌肠剂和甲硝唑在诱导急性 pouchitis 缓解方面同样有效。每年复发 pouchitis 超过 3 次的患者建议进行维持治疗,指南推荐使用环丙沙星或益生菌 VSL#3。对于抗生素难治性 pouchitis 患者,应寻找并治疗与抗生素难治性病程相关的次要因素。在本次综述中,我们将讨论溃疡性结肠炎患者 pouchitis 的预防和管理。

相似文献

1
Prevention and Medical Treatment of Pouchitis In Ulcerative Colitis.溃疡性结肠炎的袋炎预防与治疗。
Curr Drug Targets. 2019;20(13):1399-1408. doi: 10.2174/1389450120666190723130137.
2
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.慢性溃疡性结肠炎回肠储袋肛管吻合术后储袋炎的治疗与预防
Cochrane Database Syst Rev. 2015 Nov 23(11):CD001176. doi: 10.1002/14651858.CD001176.pub3.
3
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.慢性溃疡性结肠炎行回肠储袋肛管吻合术后袋炎的治疗与预防
Cochrane Database Syst Rev. 2019 Nov 30;11(11):CD001176. doi: 10.1002/14651858.CD001176.pub5.
4
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.慢性溃疡性结肠炎回肠储袋肛管吻合术后储袋炎的治疗与预防
Cochrane Database Syst Rev. 2019 May 28;5(5):CD001176. doi: 10.1002/14651858.CD001176.pub4.
5
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.慢性溃疡性结肠炎回肠储袋肛管吻合术后储袋炎的治疗与预防
Cochrane Database Syst Rev. 2010 Jun 16(6):CD001176. doi: 10.1002/14651858.CD001176.pub2.
6
Role of probiotics in the management of pouchitis.益生菌在袋炎管理中的作用。
Curr Pharm Des. 2014;20(28):4561-4. doi: 10.2174/13816128113196660724.
7
[Diagnosis and medical treatment of pouchitis in ileal pouch-anal anastomosis in patients with ulcerative colitis].[溃疡性结肠炎患者回肠储袋肛管吻合术后储袋炎的诊断与治疗]
Nihon Rinsho. 2005 May;63(5):885-9.
8
Vedolizumab for the Treatment of Chronic Pouchitis.维得利珠单抗治疗慢性袋炎。
N Engl J Med. 2023 Mar 30;388(13):1191-1200. doi: 10.1056/NEJMoa2208450.
9
A Systematic Review and Meta-analysis of Randomized Clinical Trials on the Prevention and Treatment of Pouchitis after Ileoanal Pouch Anastomosis.经肛门直肠吻合术后 pouchitis 的预防和治疗的随机临床试验的系统评价和荟萃分析。
J Gastrointest Surg. 2023 Nov;27(11):2650-2660. doi: 10.1007/s11605-023-05841-3. Epub 2023 Oct 10.
10
Diagnosis and treatment of pouchitis.储袋炎的诊断与治疗
Best Pract Res Clin Gastroenterol. 2003 Feb;17(1):75-87. doi: 10.1053/bega.2002.0348.

引用本文的文献

1
Pouchitis: insight into the pathogenesis and clinical aspects.袋炎:对发病机制和临床方面的见解
Am J Transl Res. 2022 Jul 15;14(7):4406-4425. eCollection 2022.
2
Small intestinal bacterial overgrowth in patients with inflammatory bowel disease: A case-control study.炎症性肠病患者的小肠细菌过度生长:一项病例对照研究。
Indian J Gastroenterol. 2022 Feb;41(1):96-103. doi: 10.1007/s12664-021-01211-6. Epub 2021 Aug 14.
3
High Abundance of Proteobacteria in Ileo-Anal Pouch Anastomosis and Increased Abundance of Fusobacteria Associated with Increased Pouch Inflammation.
回肠肛管吻合术中变形菌丰度高,与袋炎增加相关的梭杆菌丰度增加。
Antibiotics (Basel). 2020 May 8;9(5):237. doi: 10.3390/antibiotics9050237.